Partow Kebriaei, MD, discusses the potential shift away from transplant in acute lymphoblastic leukemia in light of ongoing advancements.
Partow Kebriaei, MD
Advertisement
Articles by Partow Kebriaei, MD
Partow Kebriaei, MD, discusses the eligibility criteria necessary for patients with acute lymphocytic leukemia to undergo stem cell transplantation.
Partow Kebriaei, MD, discusses the Iomab-B clinical trial for older patients with acute myeloid leukemia.
Advertisement
Latest Updated Articles
Dr. Kebriaei on the Iomab-B Clinical TrialPublished: February 25th 2017 | Updated:
Dr. Kebriaei on Eligibility for Stem Cell Transplant in ALLPublished: September 13th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5